 |
Adam Bonislawski is the editor of GenomeWeb's ProteoMonitor. He covers proteomics and life science mass spectrometry. E-mail Adam Bonislawski and follow his GenomeWeb Twitter account at @ProteoMonitor. |
New Vendor Collaborations, Publications, Products Suggest Clinical Mass Spec 'Ready for Prime Time'
February 15, 2013
New Vendor Collaborations, Publications, Products Suggest Clinical Mass Spec 'Ready for Prime Time'
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Immundiagnostik Deal Offers Thermo Fisher Chance to Highlight Immunoaffinity Mass Spec Workflows
October 26, 2012 / ProteoMonitor - GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor - Sera Prognostics' 4,000-Patient Validation Study Another Sign of High-Throughput Mass Spec's Arrival
March 1, 2013 / ProteoMonitor - BRIMS-Led Study Suggests Clinical Viability of SRM-MS, Vendors' Role in Clinical Proteomics Process
June 8, 2012 / ProteoMonitor - Leigh Anderson Launches New Firm to Commercialize SISCAPA Technology
June 17, 2011 / ProteoMonitor